United States Attorney's Office for the Northern District of New York

07/16/2024 | Press release | Distributed by Public on 07/16/2024 12:04

Glenville Narcotic Treatment Program Pays $300,000 Penalty for Controlled Substances Act Violations

Press Release

Glenville Narcotic Treatment Program Pays $300,000 Penalty for Controlled Substances Act Violations

Tuesday, July 16, 2024
For Immediate Release
U.S. Attorney's Office, Northern District of New York
Inspections in 2018, 2021, and 2023 Showed Repeated Recordkeeping Violations

ALBANY, NEW YORK - Conifer Park Inc. agreed to pay $300,000 to resolve allegations that it violated the Controlled Substances Act's (CSA) recordkeeping requirements.

United States Attorney Carla B. Freedman and Special Agent in Charge Frank A. Tarentino III, U.S. Drug Enforcement Administration (DEA), New York Division made the announcement.

Conifer Park is a maintenance and detoxification facility that dispenses controlled substances, including methadone and buprenorphine, to treat individuals for substance use disorder. The CSA requires entities that dispense controlled substances to maintain certain records and to conduct periodic inventories. An inspection by the DEA in 2018 revealed that Conifer Park failed to maintain accurate records or perform required inventories, and was co-mingling controlled substances among different registrants. Conifer Park subsequently agreed to comply with the CSA's recordkeeping requirements in the future and to institute an electronic recordkeeping system if it was unable to do so. DEA conducted similar inspections in 2021 and 2023 and determined that Conifer Park's recordkeeping practices continued to violate the CSA. Despite the continued non-compliance, Conifer Park did not implement an electronic recordkeeping system.

Contemporaneously with the Settlement Agreement resolving the Controlled Substances Act civil penalties, Conifer Park entered into a Memorandum of Agreement with the DEA, agreeing to implement an electronic recordkeeping system no later than November 1, 2024.

This case was investigated by DEA Albany District Office's Diversion Group. Assistant U.S. Attorney Christopher Moran represented the United States in this matter.

Updated July 16, 2024